INKON Life Technology Co., Ltd.

¥7.45As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300143Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (4.99%)
Div yield 0.26%
ROE 4.54%
Medical Devices
Beta (5Y) 0.32
PE TTM 88.27
TSR TTM (8.92%)
Mkt cap ¥7.209B
ROIC 7.40%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥8.52
14.42%
(72.04%)
Hold 7|8|3|3|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.12
0.12
0.12
0.12
27.53%
15.91%
3.19%
5.39%
Revenue¥M
457.4
477.2
465.0
478.3
(3.88%)
2.65%
(3.28%)
1.67%
Peers (US$1.081B)
Cap (US$)
PE
1.108B
—
1.106B
412.0x
1.046B
18.89x
Capital
TTM
5Y
10Y
Leveragex
3.596
(0.184)
(0.203)
EBIT/Intx
0.200
0.165
0.163
Own earn%
81.93
50.53
52.90
Sh yield%
37.48
64.96
61.88
Owners
Insiders/Inst%
2.18
31.35
Short interest%
3.38
SBC / revenue%
5.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
1–8
$1 testx
−9.1
Incr. ROIC%
4